Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems-Trading Strong Earnings Growth and Momentum -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (4458)	2/13/2001 10:36:01 AM
From: Jenna	Read Replies (2) \| Respond to of 6445

OCR great earnings play and TTN Gemmers you will NOT MAKE REAL money on scalps with NTAP, CIEN for 2 points lost and 2 points gained, but only on holding companies like these (CCMP also triggered again so its not JUST the sector that counts but the EARNINGS) for swing trades. We have from 12% to 30% gains already in our swing trades just from the last few days. ENZN has been held for 7 trading sessions already. We have held TKCI, UTSI, AXTI,IMPH, IVGN, GILD, and we rebuy swing trades that were in the past like EMBT that retrigger after pullbacks. ESRX earnings play and watch list play won't stop going up and its not one that MM's are even interested in. marketgems.com marketgems.com

To: Jenna who wrote (4458)	2/13/2001 11:57:34 AM
From: Jenna	Respond to of 6445

IMA triggered yesterday.. another lovely play in this sector (earnings play).This one should retest 40, the year high. Inverness Medical Technology Announces Record Earnings and Revenues for Quarter and Year Diabetes-related Products Continue to Drive Growth; Revenues up 35 % vs. FY '99 WALTHAM, Mass., Feb. 13 /PRNewswire/ -- Inverness Medical Technology, Inc. (Amex: IMA - news) today announced record revenues and earnings per share for both its fourth quarter and its fiscal year ended December 31, 2000. Fourth Quarter Performance For the three months ended December 31, 2000, Inverness reported a profit of $5.0 million, or $0.16 per diluted share, excluding an extraordinary charge related to the early retirement of certain subordinated notes as described below. Giving full effect to this one-time charge, net income for the quarter was $3.9 million or $0.12 per diluted share, compared to net income of $92,000 and a net loss of $0.03 per diluted share in the fourth quarter of 1999. The 1999 results included a provision for dividend payments to preferred shareholders. During the fourth quarter of 2000, the Company provided notice of an early repayment of certain of its subordinated notes. Unamortized financing costs and prepayment charges of $1.05 million related to those notes were charged to Extraordinary Loss during the fourth quarter. Since the payments actually occurred on January 29, 2001, the accompanying balance sheet does not reflect the reduction of $19.3 million from the Company's debt.